A significant shift in Canadian drug policy has occurred, as the regulators permit the legalization of psilocybin mushrooms for therapeutic purposes. Previously, these substances were strictly restricted, but a growing body of studies suggests they may offer aid for mental health conditions like depression. This development represents a key step to